Neovacs S.A.
2Patents
0Active
2Granted
20Portfolio score
Filing activity: Aug 20, 1999 → Mar 21, 2005
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7208148B2 | Chemically modified cytokines | Human Necessities | 0 | Expired |
| US7067246B1 | Method for determining prognosis of HIV infected individuals | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.